News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
898,534 Results
Type
Article (89702)
Company Profile (664)
Press Release (808146)
Multimedia
Podcasts (285)
Webinars (44)
Section
Business (267528)
Career Advice (4177)
Deals (40167)
Drug Delivery (247)
Drug Development (92164)
Employer Resources (212)
FDA (18746)
Job Trends (17566)
News (399661)
Policy (40038)
Tag
2025 Best Places to Work (26)
2026 Best Places to Work (40)
2027 BioCapital Standard (5)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (9)
2027 Biotech Beach Standard (6)
2027 Genetown Elite (2)
2027 Genetown Standard (6)
2027 NextGen (5)
2027 Pharm Country Digital (4)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
40 Under 40 (4)
Academia (3112)
Academic (2)
Accelerated approval (77)
ADA (54)
Adcomms (44)
Allergies (238)
Alliances (57001)
ALS (293)
Alzheimer's disease (2167)
Antibody-drug conjugate (ADC) (784)
Approvals (19351)
Artificial intelligence (1153)
ASCO (350)
Autoimmune disease (542)
Automation (85)
Bankruptcy (414)
Belgium (45)
Best Places to Work (12636)
BIO (84)
Biologics (124)
Biomarkers (1)
BIOSECURE Act (23)
Biosimilars (309)
BioSpace Insights (272)
Biotechnology (340)
Bispecific (64)
Bladder cancer (253)
Brain cancer (105)
Breast cancer (987)
Cancer (8116)
Cardiovascular disease (689)
Career advice (3640)
Career pathing (65)
CAR-T (466)
CDC (82)
CDMO (241)
Celiac Disease (7)
Cell-line development (2)
Cell therapy (1286)
Cervical cancer (69)
Clinical research (81302)
Collaboration (2910)
Commercialization (77)
Company closure (10)
Compensation (1948)
Complete response letters (129)
COVID-19 (3089)
CRISPR (155)
CRO (10)
C-suite (1719)
Cystic fibrosis (183)
Data (11243)
Decentralized trials (4)
Denatured (113)
Depression (230)
Dermatology (209)
Diabetes (856)
Diagnostics (7957)
Digital health (88)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (570)
Drug pricing (255)
Drug shortages (41)
Duchenne muscular dystrophy (389)
Earnings (104833)
Editorial (85)
Employer branding (27)
Employer resources (184)
ESMO (441)
Events (142073)
Executive appointments (1386)
Eye disease (28)
FDA (23906)
Fibrodysplasia Ossificans Progressiva (17)
Fragile X (6)
Friedreich's ataxia (29)
Frontotemporal dementia (43)
Funding (2400)
Gene editing (323)
Generative AI (116)
Gene therapy (997)
GLP-1 (1419)
Government (5638)
Grass and pollen (8)
Guidances (446)
Healthcare (21531)
Hematology (240)
HIV (128)
Huntington's disease (94)
Idiopathic pulmonary fibrosis (16)
IgA nephropathy (155)
Immunology and inflammation (434)
Immuno-oncology (167)
Indications (302)
Infectious disease (3551)
Inflammatory bowel disease (286)
Inflation Reduction Act (17)
Influenza (168)
Intellectual property (393)
Interviews (830)
IPO (18072)
IRA (61)
Job creations (5211)
Job search strategy (2883)
JPM (73)
Kidney cancer (32)
Kidney disease (183)
Labor market (154)
Layoffs (734)
Leadership (70)
Legal (10180)
Licensing (141)
Liver cancer (121)
Longevity (58)
Lung cancer (1118)
Lung diease (27)
Lymphoma (572)
Machine learning (78)
Management (72)
Manufacturing (1673)
Marketing (43)
MASH (260)
Medical affairs (6)
Medical device (15491)
Medtech (15832)
Melanoma (255)
Mergers & acquisitions (23659)
Metabolic disorders (2182)
Middle East (2)
mRNA (348)
Multiple sclerosis (264)
Multispecific (7)
NASH (24)
Netherlands (44)
Neurodegenerative disease (642)
Neuropsychiatric disorders (155)
Neuroscience (4395)
Neurotech (4)
NextGen: Class of 2026 (7718)
Non-profit (5176)
Now hiring (103)
Obesity (1032)
Opinion (411)
Ovarian cancer (303)
Pain (355)
Pancreatic cancer (462)
Parkinson's disease (497)
Partnered (54)
Patents (822)
Patient advocacy (9)
Patient recruitment (989)
Patient selection (124)
Peanut (81)
People (69196)
Peptides (46)
Pharmaceutical (83)
Pharmacy benefit managers (43)
Phase 1 (25078)
Phase 2 (35321)
Phase 3 (26618)
Pipeline (14809)
Policy (435)
Postmarket research (3561)
Preclinical (11221)
Press Release (74)
Prostate cancer (415)
Psychedelics (105)
Radioligand (3)
Radiopharmaceuticals (452)
Rare diseases (1623)
Real estate (7479)
Recruiting (84)
Regenerative medicine (40)
Regulatory (31951)
Reports (104)
Research institute (2824)
Resumes & cover letters (657)
Rett syndrome (60)
RNA editing (39)
RSV (107)
Saudi Arabia (1)
Schizophrenia (231)
Series A (411)
Series B (287)
Series C (1)
Service/supplier (17)
Sickle cell disease (153)
Special edition (38)
Spinal muscular atrophy (201)
Sponsored (61)
Startups (4409)
State (2)
Stem cells (8)
Stomach cancer (24)
Substance use disorders (23)
Supply chain (175)
Switzerland (25)
Tariffs (109)
Tax incentives (2)
The Weekly (169)
Vaccines (1458)
Venture capital (188)
Weight loss (686)
Wet AMD (8)
Women's health (191)
Women in leadership (2)
Worklife (28)
Date
Today (152)
Last 7 days (916)
Last 30 days (4092)
Last 365 days (34091)
2026 (31164)
2025 (33214)
2024 (37866)
2023 (42564)
2022 (53927)
2021 (58720)
2020 (57662)
2019 (51333)
2018 (39119)
2017 (37186)
2016 (38329)
2015 (44431)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1311)
Alabama (118)
Alaska (7)
Arizona (495)
Arkansas (17)
Asia (53231)
Australia (9377)
California (17438)
Canada (4801)
China (2077)
Colorado (776)
Connecticut (779)
Delaware (550)
Europe (122917)
Florida (2642)
Georgia (567)
Hawaii (5)
Idaho (70)
Illinois (1507)
India (158)
Indiana (787)
Iowa (37)
Japan (790)
Kansas (161)
Kentucky (69)
Louisiana (73)
Maine (99)
Maryland (2056)
Massachusetts (12620)
Michigan (477)
Minnesota (959)
Mississippi (8)
Missouri (191)
Montana (38)
Nebraska (31)
Nevada (209)
New Hampshire (94)
New Jersey (4625)
New Mexico (38)
New York (4546)
North Carolina (2256)
North Dakota (14)
Northern California (8907)
Ohio (545)
Oklahoma (32)
Oregon (55)
Pennsylvania (3344)
Puerto Rico (38)
Rhode Island (66)
South America (1674)
South Carolina (105)
South Dakota (2)
Southern California (6955)
Tennessee (291)
Texas (2903)
United States (61827)
Utah (531)
Vermont (2)
Virginia (437)
Washington D.C. (90)
Washington State (1391)
West Virginia (4)
Wisconsin (200)
Wyoming (6)
898,534 Results for "a2 biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immutep Receives A$2.16 million French R&D Tax Incentive
October 28, 2026
·
2 min read
Press Releases
A2 Biotherapeutics Presents Updated Safety and Efficacy Data from EVEREST-2 and DENALI-1 Clinical Studies during 2026 Annual Meeting of the Society for Immunotherapy of Cancer
November 3, 2026
·
11 min read
Press Releases
Inside Turkey’s Hair Restoration Boom: Why Accreditation and Patient-Safety Governance Now Define a $2 Billion Sector
Turkey’s medical-tourism market reached an estimated $3.5 billion in 2025, with hair transplantation accounting for 51.9% of the market, as new certification requirements and concerns over unlicensed procedures increase pressure for stronger clinical governance.
October 23, 2026
·
5 min read
Press Releases
A2 Biotherapeutics Presents Early Safety and Efficacy Data from the DENALI-1 Study of A2B395, Highlighting First Reported Case of Complete Response to CAR T-Cell Therapy in Anal Cancer and Partial Response at 6 Months in Refractory Head & Neck Cancer
September 15, 2026
·
7 min read
IPO
City’s IPO soars to $200M, with proceeds supporting thromboembolic disease pipeline
City Therapeutics will join a slew of biotechs that have entered the public markets this year, with a $200 million raise that landed above expectations.
October 16, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma
October 26, 2026
·
9 min read
Press Releases
A2 Biotherapeutics Receives U.S. FDA Fast Track Designation for A2B543, a Logic-Gated CAR T-Cell Therapy Enhanced with a Membrane-Tethered IL-12 Booster
April 2, 2026
·
2 min read
FDA
AstraZeneca buys into Summit, UniQure drops on 4-year data, FDA on a roll
Summit Therapeutics scores a $2 billion equity investment from AstraZeneca to support ivonescimab’s late-stage development; uniQure crashes after four-year data from its Huntington’s disease gene therapy failed to impress; Kyverna Therapeutics brings new light to a struggling CAR T space in autoimmune disease.
September 30, 2026
·
1 min read
·
Jef Akst
Breast cancer
AstraZeneca’s newly approved cancer pill fails late-stage study, blocking path to bigger market
SERENA-4 was assessing AstraZeneca’s Etcamah as a first-line option for certain patients with advanced breast cancer—a setting that could have meant a $2.9 billion opportunity for the drug.
September 14, 2026
·
2 min read
·
Tristan Manalac
Press Releases
A2 Biotherapeutics Doses First Patient in EVEREST-2 Study with A2B543, a Logic-Gated CAR T Cell Therapy Enhanced with a Membrane-Tethered IL-12 Booster
February 26, 2026
·
5 min read
1 of 89,854
Next